Đang chuẩn bị liên kết để tải về tài liệu:
Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: A population-based cohort study in Ontario, Canada

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG Tải xuống

For novel cancer treatments, effectiveness in clinical practice is not always aligned with clinical efficacy results. As such it is important to understand a treatment’s real-world effectiveness. We examined real-world population-based comparative effectiveness of second-line ipilimumab versus non-ipilimumab treatments (chemotherapy or targeted treatments). | Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma A population-based cohort study in Ontario Canada